Sab BiotherapeuticsSABS

13F holders, Q4 2025 (December 31)
48holders +14
20new positions
7sold out
2famous investors
$3.74avg. 13F price*

At the end of Q4 2025, 48 institutions reported holding Sab Biotherapeutics Inc. (SABS) in their 13F filings, up 14 from Q3 2025. 20 opened new positions and 7 sold out. The largest holders were Vivo Capital, LLC ($42.7M), Commodore Capital LP ($16.5M) and Ra Capital Management, L.P. ($16.5M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Sab Biotherapeutics Inc.
CUSIP
78397T202
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080100 Q1 2024: 24Q1 2024Q2 2024: 22Q2 2024Q3 2024: 25Q3 2024Q4 2024: 25Q4 2024Q1 2025: 26Q1 2025Q2 2025: 25Q2 2025Q3 2025: 34Q3 2025Q4 2025: 48Q4 2025Q1 2026: 76Q1 2026Q2 2026: 87Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions20$22.9M
Exits7$3.3M

All 13F filers, Q3 2025 → Q4 2025: 7,762,740 shares bought and 1,643,069 shares sold, net +6,119,671 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 48 holders

Vivo Capital, LLC 2.76% No change 11,420,000 $42.7M
Commodore Capital LP 1.10% No change 4,401,500 $16.5M
Ra Capital Management, L.P. 0.17% No change 4,401,500 $16.5M
Woodline Partners LP 0.04% No change 2,850,881 $10.7M
Spruce Street Capital LP 2.72% — 2,198,502 $8.2M
Sessa Capital IM, L.P. 0.16% No change 2,198,457 $8.2M
Blackstone Inc. 0.03% New 2,143,585 $8.0M
Vanguard Group Inc. 0.00% Add +405.0% 1,847,136 $6.9M
Perceptive Advisors LLC 0.06% New 803,210 $3.0M
Propel Bio Management, LLC 2.08% New 652,881 $2.4M
Jefferies Financial Group Inc. 0.02% New 580,328 $2.2M
Balyasny Asset Management L.P. 0.00% New 475,439 $1.8M
Millennium Management 0.00% New 324,090 $1.2M
HB Wealth Management, LLC 0.01% No change 307,500 $1.2M
Ameriprise Financial Inc. 0.00% New 283,645 $1.1M
Marshall Wace, LLP 0.00% New 236,460 $884K
Simplify Asset Management Inc. 0.01% New 208,227 $779K
AWM Investment Company, Inc. 0.07% No change 200,000 $748K
Stempoint Capital LP 0.09% New 146,558 $548K
Geode Capital Management, LLC 0.00% Add +39.4% 119,517 $447K
ExodusPoint Capital Management, LP 0.00% New 86,113 $322K
Goldman Sachs Group Inc. 0.00% Add +357.6% 51,348 $192K
Pathstone Holdings, LLC 0.00% No change 50,650 $189K
OMERS ADMINISTRATION Corp 0.00% New 42,000 $157K
Qube Research & Technologies Ltd 0.00% New 31,147 $116K
Citigroup Inc. 0.00% Add +3502.6% 29,974 $112K
Verition Fund Management LLC 0.00% New 26,867 $100K
ADAR1 Capital Management, LLC 0.01% Add +75.6% 26,344 $99K
Persistent Asset Partners Ltd 0.04% New 19,790 $74K
Focus Partners Wealth 0.00% New 19,201 $72K
First PREMIER Bank 0.02% No change 18,986 $71K
Citadel Advisors 0.00% New 17,650 $66K
BlackRock, Inc. 0.00% Add +171.9% 17,239 $64K
Northern Trust Corp. 0.00% Add +44.1% 16,412 $61K
Fifth Lane Capital, LP 0.07% New 15,000 $56K
State Street Corp. 0.00% New 13,122 $49K
Kestra Advisory Services, LLC 0.00% Reduce -3.2% 11,550 $43K
Bank of America Corp. 0.00% Add +14241.9% 10,613 $40K
Caxton Corp. 0.92% Reduce -3.7% 10,527 $39K
State of Wyoming 0.00% New 8,971 $34K
UBS Group AG 0.00% Reduce -44.0% 7,398 $28K
Osaic Holdings, Inc. 0.00% Add +4.2% 5,024 $19K
Morgan Stanley 0.00% Add +2436.9% 4,262 $16K
JPMorgan Chase & Co. 0.00% Add +2187.4% 1,990 $7K
MAI Capital Management 0.00% No change 217 $812
GS Investments, Inc. 0.00% No change 200 $748
Harbour Investments, Inc. 0.00% No change 50 $187
SBI Securities Co., Ltd. 0.00% Reduce -3.9% 50 $187

"% of holder's portfolio" is SABS's weight in each manager's 13F, not the share of Sab Biotherapeutics Inc. the manager owns.